Literature DB >> 21786365

Functional consequences and structural interpretation of mutations of human choline acetyltransferase.

Xin-Ming Shen1, Thomas O Crawford, Joan Brengman, Gyula Acsadi, Susan Iannaconne, Emin Karaca, Chaouky Khoury, Jean K Mah, Shimon Edvardson, Zeljko Bajzer, David Rodgers, Andrew G Engel.   

Abstract

Choline acetyltransferase (ChAT; EC 2.3.1.6) catalyzes synthesis of acetylcholine from acetyl-CoA (AcCoA) and choline in cholinergic neurons. Mutations in CHAT cause potentially lethal congenital myasthenic syndromes associated with episodic apnea (ChAT-CMS). Here, we analyze the functional consequences of 12 missense and one nonsense mutations of CHAT in 11 patients. Nine of the mutations are novel. We examine expression of the recombinant missense mutants in Bosc 23 cells, determine their kinetic properties and thermal stability, and interpret the functional effects of 11 mutations in the context of the atomic structural model of human ChAT. Five mutations (p.Trp421Ser, p.Ser498Pro, p.Thr553Asn, p.Ala557Thr, and p.Ser572Trp) reduce enzyme expression to less than 50% of wild-type. Mutations with severe kinetic effects are located in the active-site tunnel (p.Met202Arg, p.Thr553Asn, and p.Ala557Thr) or adjacent to the substrate binding site (p.Ser572Trp), or exert their effect allosterically (p.Trp421Ser and p.Ile689Ser). Two mutations with milder kinetic effects (p.Val136Met and p.Ala235Thr) are also predicted to act allosterically. One mutation (p.Thr608Asn) below the nucleotide binding site of CoA enhances dissociation of AcCoA from the enzyme-substrate complex. Two mutations introducing a proline residue into an α-helix (p.Ser498Pro and p.Ser704Pro) impair the thermal stability of ChAT.
© 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21786365      PMCID: PMC3196808          DOI: 10.1002/humu.21560

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  34 in total

1.  Rapsyn mutations in hereditary myasthenia: distinct early- and late-onset phenotypes.

Authors:  G Burke; J Cossins; S Maxwell; G Owens; A Vincent; S Robb; M Nicolle; D Hilton-Jones; J Newsom-Davis; J Palace; D Beeson
Journal:  Neurology       Date:  2003-09-23       Impact factor: 9.910

2.  Choline acetyltransferase structure reveals distribution of mutations that cause motor disorders.

Authors:  Yiying Cai; Ciarán N Cronin; Andrew G Engel; Kinji Ohno; Louis B Hersh; David W Rodgers
Journal:  EMBO J       Date:  2004-05-06       Impact factor: 11.598

3.  A rapid radiochemical method for the determination of choline acetyltransferase.

Authors:  F Fonnum
Journal:  J Neurochem       Date:  1975-02       Impact factor: 5.372

4.  Rapsyn mutations in humans cause endplate acetylcholine-receptor deficiency and myasthenic syndrome.

Authors:  Kinji Ohno; Andrew G Engel; Xin-Ming Shen; Duygu Selcen; Joan Brengman; C Michel Harper; Akira Tsujino; Margherita Milone
Journal:  Am J Hum Genet       Date:  2002-01-14       Impact factor: 11.025

5.  Three novel COLQ mutations and variation of phenotypic expressivity due to G240X.

Authors:  Y A Shapira; M E Sadeh; M P Bergtraum; A Tsujino; K Ohno; X M Shen; J Brengman; S Edwardson; I Matoth; A G Engel
Journal:  Neurology       Date:  2002-02-26       Impact factor: 9.910

6.  Mutation causing severe myasthenia reveals functional asymmetry of AChR signature cystine loops in agonist binding and gating.

Authors:  Xin-Ming Shen; Kinji Ohno; Akira Tsujino; Joan M Brengman; Monique Gingold; Steven M Sine; Andrew G Engel
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

7.  Congenital myasthenic syndrome due to a novel missense mutation in the gene encoding choline acetyltransferase.

Authors:  Carolin Schmidt; Angela Abicht; Klaus Krampfl; Wolfgang Voss; Rolf Stucka; Gina Mildner; Sofia Petrova; Ulrike Schara; Wilhelm Mortier; Johannes Bufler; Angela Huebner; Hanns Lochmüller
Journal:  Neuromuscul Disord       Date:  2003-03       Impact factor: 4.296

8.  Identification of pathogenic mutations in the human rapsyn gene.

Authors:  Vanessa Dunne; Ricardo A Maselli
Journal:  J Hum Genet       Date:  2003-03-05       Impact factor: 3.172

9.  Myasthenic syndrome caused by mutation of the SCN4A sodium channel.

Authors:  Akira Tsujino; Chantal Maertens; Kinji Ohno; Xin-Ming Shen; Taku Fukuda; C Michael Harper; Stephen C Cannon; Andrew G Engel
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-23       Impact factor: 11.205

10.  Choline acetyltransferase mutations in myasthenic syndrome due to deficient acetylcholine resynthesis.

Authors:  Ricardo A Maselli; Darlene Chen; Delores Mo; Constance Bowe; Grace Fenton; Robert L Wollmann
Journal:  Muscle Nerve       Date:  2003-02       Impact factor: 3.217

View more
  14 in total

Review 1.  Current status of the congenital myasthenic syndromes.

Authors:  Andrew G Engel
Journal:  Neuromuscul Disord       Date:  2011-11-21       Impact factor: 4.296

Review 2.  New horizons for congenital myasthenic syndromes.

Authors:  Andrew G Engel; Xin-Ming Shen; Duygu Selcen; Steven Sine
Journal:  Ann N Y Acad Sci       Date:  2012-12       Impact factor: 5.691

Review 3.  Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatment.

Authors:  Andrew G Engel; Xin-Ming Shen; Duygu Selcen; Steven M Sine
Journal:  Lancet Neurol       Date:  2015-04       Impact factor: 44.182

4.  Choline Acetyltransferase Mutations Causing Congenital Myasthenic Syndrome: Molecular Findings and Genotype-Phenotype Correlations.

Authors:  Juan Arredondo; Marian Lara; Sídney M Gospe; Claudio G Mazia; Maria Vaccarezza; Marcela Garcia-Erro; Constance M Bowe; Celia H Chang; Michelle M Mezei; Ricardo A Maselli
Journal:  Hum Mutat       Date:  2015-07-24       Impact factor: 4.878

Review 5.  Congenital myasthenic syndromes in 2012.

Authors:  Andrew G Engel
Journal:  Curr Neurol Neurosci Rep       Date:  2012-02       Impact factor: 5.081

6.  Impaired Presynaptic High-Affinity Choline Transporter Causes a Congenital Myasthenic Syndrome with Episodic Apnea.

Authors:  Stéphanie Bauché; Seana O'Regan; Yoshiteru Azuma; Fanny Laffargue; Grace McMacken; Damien Sternberg; Guy Brochier; Céline Buon; Nassima Bouzidi; Ana Topf; Emmanuelle Lacène; Ganaelle Remerand; Anne-Marie Beaufrere; Céline Pebrel-Richard; Julien Thevenon; Salima El Chehadeh-Djebbar; Laurence Faivre; Yannis Duffourd; Federica Ricci; Tiziana Mongini; Chiara Fiorillo; Guja Astrea; Carmen Magdalena Burloiu; Niculina Butoianu; Carmen Sandu; Laurent Servais; Gisèle Bonne; Isabelle Nelson; Isabelle Desguerre; Marie-Christine Nougues; Benoit Bœuf; Norma Romero; Jocelyn Laporte; Anne Boland; Doris Lechner; Jean-François Deleuze; Bertrand Fontaine; Laure Strochlic; Hanns Lochmuller; Bruno Eymard; Michèle Mayer; Sophie Nicole
Journal:  Am J Hum Genet       Date:  2016-08-25       Impact factor: 11.025

Review 7.  Congenital Myasthenic Syndromes in 2018.

Authors:  Andrew G Engel
Journal:  Curr Neurol Neurosci Rep       Date:  2018-06-12       Impact factor: 5.081

8.  Analysis of Caenorhabditis elegans acetylcholine synthesis mutants reveals a temperature-sensitive requirement for cholinergic neuromuscular function.

Authors:  Janet S Duerr; John R McManus; John A Crowell; James B Rand
Journal:  Genetics       Date:  2021-08-09       Impact factor: 4.402

9.  Chaperone-Mediated Regulation of Choline Acetyltransferase Protein Stability and Activity by HSC/HSP70, HSP90, and p97/VCP.

Authors:  Trevor M Morey; Warren Winick-Ng; Claudia Seah; R Jane Rylett
Journal:  Front Mol Neurosci       Date:  2017-12-12       Impact factor: 5.639

Review 10.  Inherited disorders of the neuromuscular junction: an update.

Authors:  Pedro M Rodríguez Cruz; Jacqueline Palace; David Beeson
Journal:  J Neurol       Date:  2014-10-11       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.